STRS Ohio’s Utah Medical Products UTMD Stock Holding History

STRS Ohio’s Portfolio UTMD Stock Details UTMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,000	Closed	-$66.8K	–	2072
2024 Q2	$66.8K	Sell	1,000 -3,200	-76%	-$218K	﹤0.01%	1768
2024 Q1	$298K	Sell	4,200 -1,600	-28%	-$120K	﹤0.01%	1438
2023 Q4	$488K	Hold	5,800	–	–	﹤0.01%	1296
2023 Q3	$498K	Hold	5,800	–	–	﹤0.01%	1267
2023 Q2	$540K	Hold	5,800	–	–	﹤0.01%	1243
2023 Q1	$549K	Hold	5,800	–	–	﹤0.01%	1255
2022 Q4	$583K	Sell	5,800 -500	-8%	-$45.6K	﹤0.01%	1239
2022 Q3	$537K	Hold	6,300	–	–	﹤0.01%	1306
2022 Q2	$541K	Buy	6,300 +400	+7%	+$34.1K	﹤0.01%	1318
2022 Q1	$530K	Hold	5,900	–	–	﹤0.01%	1419
2021 Q4	$590K	Hold	5,900	–	–	﹤0.01%	1431
2021 Q3	$547K	Hold	5,900	–	–	﹤0.01%	1475
2021 Q2	$501K	Buy	5,900 +600	+11%	+$51.9K	﹤0.01%	1559
2021 Q1	$458K	Hold	5,300	–	–	﹤0.01%	1606
2020 Q4	$446K	Hold	5,300	–	–	﹤0.01%	1525
2020 Q3	$423K	Hold	5,300	–	–	﹤0.01%	1425
2020 Q2	$469K	Hold	5,300	–	–	﹤0.01%	1350
2020 Q1	$498K	Sell	5,300 -700	-12%	-$65K	﹤0.01%	1134
2019 Q4	$647K	Sell	6,000 -100	-2%	-$10.1K	﹤0.01%	1255
2019 Q3	$584K	Sell	6,100 -900	-13%	-$83.6K	﹤0.01%	1145
2019 Q2	$669K	Buy	7,000 +200	+3%	+$16.8K	﹤0.01%	1052
2019 Q1	$600K	Hold	6,800	–	–	﹤0.01%	1149
2018 Q4	$564K	Hold	6,800	–	–	﹤0.01%	1141
2018 Q3	$640K	Hold	6,800	–	–	﹤0.01%	1248
2018 Q2	$749K	Sell	6,800 -900	-12%	-$94K	﹤0.01%	1122
2018 Q1	$761K	Buy	7,700 +3,500	+83%	+$312K	﹤0.01%	1051
2017 Q4	$341K	Buy	4,200 +1,500	+56%	+$117K	﹤0.01%	1407
2017 Q3	$198K	Hold	2,700	–	–	﹤0.01%	1541
2017 Q2	$195K	Buy	2,700 +200	+8%	+$13.2K	﹤0.01%	1527
2017 Q1	$155K	Hold	2,500	–	–	﹤0.01%	1563
2016 Q4	$181K	Hold	2,500	–	–	﹤0.01%	1562
2016 Q3	$149K	Sell	2,500 -100	-4%	-$6.36K	﹤0.01%	1599
2016 Q2	$163K	Buy	2,600 +700	+37%	+$45.1K	﹤0.01%	1604
2016 Q1	$118K	Buy	1,900 +1,500	+375%	+$88.5K	﹤0.01%	1626
2015 Q4	$23K	Hold	400	–	–	﹤0.01%	1843
2015 Q3	$21K	Hold	400	–	–	﹤0.01%	1817
2015 Q2	$23K	Hold	400	–	–	﹤0.01%	1811
2015 Q1	$23K	Hold	400	–	–	﹤0.01%	1755
2014 Q4	$24K	Hold	400	–	–	﹤0.01%	1679
2014 Q3	$20K	Hold	400	–	–	﹤0.01%	1736
2014 Q2	$21K	Hold	400	–	–	﹤0.01%	1661
2014 Q1	$23K	Hold	400	–	–	﹤0.01%	1667
2013 Q4	$23K	Sell	400 -100	-20%	-$5.49K	﹤0.01%	1701
2013 Q3	$30K	Hold	500	–	–	﹤0.01%	1769
2013 Q2	$27K	Buy	+500	New	+$23.5K	﹤0.01%	1787

Other funds holding UTMD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

STRS Ohio's UTMD Position: Q3 2024 in Review

STRS Ohio sold out of Utah Medical Products (UTMD) in Q3 2024, closing a stake of 1,000 shares — an estimated $66.8K sold.

STRS Ohio first reported a position in UTMD in Q2 2013 and held it in 45 quarters. The position peaked at $761K in Q1 2018. 110 funds tracked by Wall St. Rank hold UTMD as of Q3 2024.

STRS Ohio reported no remaining Utah Medical Products position as of Q3 2024 after selling out during the quarter.
STRS Ohio sold 1,000 Utah Medical Products shares in Q3 2024, an estimated $66.8K.
STRS Ohio first reported a position in Utah Medical Products in Q2 2013 and held it in 45 quarters.
STRS Ohio's Utah Medical Products position peaked at $761K in Q1 2018.
110 funds tracked by Wall St. Rank held Utah Medical Products as of Q3 2024.

Based on STRS Ohio's 13F filing for Q3 2024, filed 1 Nov 2024.